Shares of Health Care sector company IQVIA moved -2.0% today, and are now trading at a price of $138.97. The Large-Cap stock's daily volume was 230,123 compared to its average volume of 1,994,891. The S&P 500 index returned a -0.0% performance.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. The company is based in Durham and has 89,000 full time employees. Its market capitalization is $24,041,809,920.
20 analysts are following IQVIA and have set target prices ranging from $160.0 to $268.0 per share. On average, they have given the company a rating of buy. At today's prices, IQV is trading -29.71% away from its average analyst target price of $197.72 per share.
Over the last year, IQV shares have gone down by -39.7%, which represents a difference of -50.9% when compared to the S&P 500. The stock's 52 week high is $252.88 per share and its 52 week low is $135.97. With average free cash flows of $1.61 Billion that have been growing at an average rate of 14.2% over the last 5 years, IQVIA declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 2,716,000 | 602,000 | 2,114,000 | 40.93 |
| 2023 | 2,149,000 | 649,000 | 1,500,000 | -5.42 |
| 2022 | 2,260,000 | 674,000 | 1,586,000 | -31.1 |
| 2021 | 2,942,000 | 640,000 | 2,302,000 | 71.41 |
| 2020 | 1,959,000 | 616,000 | 1,343,000 | 60.84 |
| 2019 | 1,417,000 | 582,000 | 835,000 |
